Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

Nathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov, Anna Grinman, Bella Ungar, Henit Yanai, Haim Leibovitzh, Naomi Fliss Isakov, Ayal Hirsch, Einat Ritter, Yulia Ron, Ariella Bar Gil Shitrit, Eran Goldin, Iris Dotan, Shomron Ben Horin, Charlie W. Lees, Nitsan Maharshak*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences